Insider · CIK 0001594604

BILINSKY IGOR

Reports to the SEC for 5 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001594604

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−7,813 sh	—	—	46,878
2026-09-08	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+7,813 sh	—	—	146,050
2026-09-08	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−3,976 sh	$8.70	−$34.6K	142,074
2026-09-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,789 sh	—	—	142,709
2026-09-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−4,472 sh	$8.28	−$37K	138,237
2026-09-01	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,789 sh	—	—	17,580
2026-06-05	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+7,813 sh	—	—	137,896
2026-06-05	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−7,813 sh	—	—	54,691
2026-06-05	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−3,976 sh	$4.23	−$16.8K	133,920
2026-06-01	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,790 sh	—	—	26,369
2026-06-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,790 sh	—	—	134,556
2026-06-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−4,473 sh	$3.96	−$17.7K	130,083
2026-03-09	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+118K sh	—	—	117,500
2026-03-05	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−16.6K sh	$4.58	−$76.2K	125,766
2026-03-05	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−31.2K sh	—	—	62,504
2026-03-05	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+31.2K sh	—	—	142,394
2026-03-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−6,903 sh	$3.79	−$26.2K	111,148
2026-03-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,790 sh	—	—	35,159
2026-03-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,517 sh	—	—	0
2026-03-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+12.3K sh	—	—	118,051
2025-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,516 sh	—	—	3,517
2025-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−1,786 sh	$2.14	−$3,822.04	105,744
2025-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,516 sh	—	—	107,530
2025-12-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−4,464 sh	$2.23	−$9,954.72	104,014
2025-12-01	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,789 sh	—	—	108,478
2025-12-01	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,789 sh	—	—	43,949
2025-09-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,790 sh	—	—	52,738
2025-09-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,516 sh	—	—	7,033
2025-09-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+12.3K sh	—	—	105,939
2025-09-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−6,250 sh	$2.19	−$13.7K	99,689
2025-06-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,789 sh	—	—	61,528
2025-06-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,516 sh	—	—	10,549
2025-06-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−6,250 sh	$1.76	−$11K	93,633
2025-06-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+12.3K sh	—	—	99,883
2025-03-05	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+93.8K sh	—	—	93,750
2025-03-03	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−33.3K sh	$4.04	−$135K	87,578
2025-03-03	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+62.1K sh	—	—	120,880
2025-03-03	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,516 sh	—	—	14,065
2025-03-03	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−58.6K sh	—	—	70,317
2025-01-14	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,813 sh	—	—	60,352
2025-01-14	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,813 sh	—	—	0
2025-01-14	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−1,578 sh	$5.89	−$9,294.42	58,774
2024-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,516 sh	—	—	59,323
2024-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,516 sh	—	—	17,581
2024-12-02	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−1,784 sh	$9.07	−$16.2K	57,539
2024-10-14	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,813 sh	—	—	2,813
2024-10-14	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−1,428 sh	$9.77	−$14K	55,807
2024-10-14	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,813 sh	—	—	57,235
2024-09-03	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,516 sh	—	—	44,659
2024-09-03	IOVAIOVANCE BIOTHERAPEUTICS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+23.4K sh	—	—	66,313

Recent filings

Accepted (ET)
Sep 104
BILINSKY IGOR0001104659-26-106750
SEC(opens sec.gov)
Sep 34
BILINSKY IGOR0001104659-26-105099
SEC(opens sec.gov)
Jun 94
BILINSKY IGOR0001104659-26-071891
SEC(opens sec.gov)
Jun 34
BILINSKY IGOR0001104659-26-070149
SEC(opens sec.gov)
Mar 114
BILINSKY IGOR0001104659-26-026442
SEC(opens sec.gov)
Mar 64
BILINSKY IGOR0001104659-26-024759
SEC(opens sec.gov)
Mar 44
BILINSKY IGOR0001104659-26-023538
SEC(opens sec.gov)

Companies

Address

C/O IOVANCE BIOTHERAPEUTICS, INC. 825 INDUSTRIAL ROAD, SUITE 100

SAN CARLOS, CA, 94070